Skip to main
ADUS

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 11%
Sell 11%
Strong Sell 0%

Bulls say

Addus HomeCare is well positioned in the in-home care services industry with the potential for growth, evidenced by recent acquisitions in Indiana and its M&A pipeline. The company's positive outlook is supported by its strong financial position, with a cash balance of $103M and an expected $120M in free cash flow in 2026. While there may be some short-term challenges in certain segments, the overall positive trends in organic growth and improved utilization show the company's strength in the market.

Bears say

Addus HomeCare is struggling to meet its LT growth targets due to potential funding reforms, labor constraints, and dampened revenue growth in the Home Health segment. Despite maintaining steady EBITDA estimates, the uncertainty surrounding Medicaid funding and weather conditions have hindered the company's ability to meet revenue projections and overall performance expectations. While the company's financials remain firm, these external factors continue to weigh on the company's stock price.

Addus HomeCare (ADUS) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 11% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 9 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $132.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $132.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.